| 1 |
Hostle EA, Bagshaw SM, Bellomo R, et al. Epidemiology of acute kidney injury in critally ill patients: the multinational AKI-EPI study[J]. Intensive Care Med, 2015, 41 (8): 1411-1423.
|
| 2 |
Liborio AB, Leite TT, Neves FM, et al. AKI complications in critiallu ill patients: association with mortality rates and RRT[J]. Clin J Am Soc Nephrol, 2015, 10 (1): 21-28.
|
| 3 |
Srisawat N, Sileanu FE, Murugan R, et al. Variation in risk and mortality of acute kidney injury in critically ill patients: a multicenter study[J]. Am J Nephrol, 2015, 41 (1): 81-88.
|
| 4 |
De Corte W, Dhondt A, Vanholder R, et al. Long-term outcome in ICU patients with acute kidney injury treated with renal repavement therapy: a prospective cohort study[J]. Crit Care, 2016, 20 (1): 256.
|
| 5 |
Barbar SD, Clere-Jehl R, Bourredjem A, et al. Timing of renal-replacement therapy in patients with acute kidney injury and sepsis[J]. N Engl J Med, 2018, 379 (15): 1431-1442.
|
| 6 |
Gaudry S, Hajage D, Schortgen F, et al. Initiation strategies for renal-replacement therapy in the intensive care unit[J]. N Engl J Med, 2016, 375 (2): 122-133.
|
| 7 |
Rachoin JS, Weisberg LS. Renal replacement therapy in the ICU[J]. Crit Care Med, 2019, 47 (5): 715-721.
|
| 8 |
Shingarev R, Wille K, Tolwani A. Management of complications in renal replacement therapy[J]. Senin Dial, 2011, 24 (2): 164-168.
|
| 9 |
Lai TS, Shiao CC, Wang JJ, et al. Earlier versus later initiation of renal replacement therapy among critically ill patients with acute kidney injury: a systematic review and meta-analysis of randomized controlled trials[J]. Ann Intensive Care, 2017, 7 (1): 38.
|
| 10 |
Bhatt GC, Das RR. Early versus late initiation of renal replacement therapy in patients with acute kidney injury--a systematic review & meta-analysis of randomized controlled trials[J]. BMC Nephrol, 2017, 18 (1): 78.
|
| 11 |
Malhotra R, Siew ED. Biomarkers for the early detection and prognosis of acute kidney injury[J]. Clin J Am Soc Nephrol, 2017, 12 (1): 149-173.
|
| 12 |
Klein SJ, Brandtner Ak, Lehner GF, et al. Biomarkers for prediction of renal replacement therapy in acute kidney injury: a systematic review and meta-analysis[J]. Intensice Care Med, 2018, 44 (3): 323-336.
|
| 13 |
Cruz DN, de Cal M, Garzotto F, et al. Plasma neutrophil gelatinase-associated lipocalin is an early biomarker for acute kidney injuryin an adult ICU population[J]. Intensive Care Med, 2010, 36 (3): 444-451.
|
| 14 |
Hall IE, Yarlagadda SG, Coca SG, et al. IL-18 and urinary NGAL predict dialysis and graft recovery after kidney transplantation[J]. J Am Soc Nephrol, 2010, 21 (1): 189-197.
|
| 15 |
Haase M, Bellomo R, Devarajan P, et al. NGAL Meta-analysis Investigator Group. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis[J]. Am J Kidney Dis, 2009, 54 (6): 1012-1024.
|
| 16 |
Tiranathanagul K, Amornsuntorn S, Avihingsanon Y, et al. Potential role of neutrophil gelatinase-associated lipocalin in identifying critically ill patients with acute kidney injury stage 2-3 who subsequently require renal replacement therapy[J]. Ther Apher Dial, 2013, 17 (3): 332-338.
|